MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 222 filers reported holding MIRATI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,524,556 | +2.5% | 34,999 | -15.0% | 0.00% | – |
| Q2 2023 | $1,486,930 | -16.3% | 41,155 | -13.8% | 0.00% | – |
| Q1 2023 | $1,775,791 | -86.6% | 47,762 | -83.7% | 0.00% | -100.0% |
| Q4 2022 | $13,262,146 | -13.0% | 292,698 | +34.1% | 0.00% | -25.0% |
| Q3 2022 | $15,243,000 | -90.7% | 218,258 | -91.1% | 0.00% | -89.2% |
| Q2 2022 | $164,298,000 | +1453.8% | 2,447,460 | +1803.1% | 0.04% | +1750.0% |
| Q1 2022 | $10,574,000 | -69.1% | 128,607 | -44.8% | 0.00% | -71.4% |
| Q4 2021 | $34,193,000 | -1.5% | 233,099 | +18.8% | 0.01% | 0.0% |
| Q3 2021 | $34,709,000 | +20.4% | 196,196 | +9.9% | 0.01% | +16.7% |
| Q2 2021 | $28,833,000 | -59.3% | 178,504 | -56.8% | 0.01% | -66.7% |
| Q1 2021 | $70,822,000 | -35.4% | 413,439 | -17.1% | 0.02% | -35.7% |
| Q4 2020 | $109,557,000 | +17.4% | 498,800 | -11.2% | 0.03% | +7.7% |
| Q3 2020 | $93,305,000 | +114.7% | 561,903 | +47.6% | 0.03% | +100.0% |
| Q2 2020 | $43,458,000 | +26.9% | 380,642 | -14.5% | 0.01% | +8.3% |
| Q1 2020 | $34,233,000 | -30.0% | 445,330 | +17.4% | 0.01% | -7.7% |
| Q4 2019 | $48,887,000 | +78.2% | 379,386 | +7.7% | 0.01% | +62.5% |
| Q3 2019 | $27,436,000 | -6.9% | 352,150 | +23.1% | 0.01% | 0.0% |
| Q2 2019 | $29,473,000 | +31.5% | 286,141 | -6.4% | 0.01% | +14.3% |
| Q1 2019 | $22,418,000 | +581.8% | 305,829 | +294.5% | 0.01% | +600.0% |
| Q4 2018 | $3,288,000 | -27.8% | 77,517 | -19.8% | 0.00% | 0.0% |
| Q3 2018 | $4,551,000 | +95.2% | 96,609 | +104.3% | 0.00% | 0.0% |
| Q2 2018 | $2,331,000 | -55.4% | 47,294 | -72.2% | 0.00% | 0.0% |
| Q1 2018 | $5,228,000 | +784.6% | 170,309 | +425.5% | 0.00% | – |
| Q4 2017 | $591,000 | +64.6% | 32,408 | -67.0% | 0.00% | – |
| Q2 2017 | $359,000 | +564.8% | 98,251 | +845.4% | 0.00% | – |
| Q1 2017 | $54,000 | -88.0% | 10,393 | -84.7% | 0.00% | – |
| Q3 2016 | $450,000 | +121.7% | 68,076 | +83.2% | 0.00% | – |
| Q2 2016 | $203,000 | -59.9% | 37,162 | +36.1% | 0.00% | – |
| Q4 2014 | $506,000 | -21.2% | 27,295 | -25.6% | 0.00% | – |
| Q3 2014 | $642,000 | -35.6% | 36,685 | -26.4% | 0.00% | – |
| Q2 2014 | $997,000 | +83.9% | 49,849 | +75.2% | 0.00% | – |
| Q1 2014 | $542,000 | +21.5% | 28,447 | +6.0% | 0.00% | – |
| Q4 2013 | $446,000 | -13.7% | 26,847 | -21.4% | 0.00% | – |
| Q3 2013 | $517,000 | – | 34,147 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |